Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-30
2007-10-30
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S490000, C548S491000, C514S415000
Reexamination Certificate
active
10450894
ABSTRACT:
Compounds of formula (I)or salts or solvates thereof or physiologically functional derivatives thereof are potent binders at the EP4 receptor and are of use in the treatment or prevention of conditions such as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.
REFERENCES:
patent: 4251446 (1981-02-01), Crounse et al.
patent: 4322352 (1982-03-01), Crounse et al.
patent: 5075313 (1991-12-01), Yu et al.
patent: 5559125 (1996-09-01), Kulagowski et al.
patent: 6833387 (2004-12-01), Faull et al.
patent: WO 00/18744 (2000-04-01), None
patent: WO 00/21532 (2000-04-01), None
Yu et al (1992): STN International HCAPLUS database, Columbus (OH), accession No. 1992: 128964.
Edwards et al (1950): STN International HCAPLUS database, Columbus (OH), accession No. 1950: 734.
Demaine Derek Anthony
Giblin Gerard Martin Paul
Hosking Rachel Elizabeth
Inglis Graham George Adam
Lewell Xiao Qing
Glaxo Group Limited
Hsu Grace C.
Kinzig Charles M.
McCarthy Mary E.
Shameem Golam M. M.
LandOfFree
Indole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3895398